TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3257670

Group type: EXPERIMENTAL
Intervention: Single-dose treatment (trimethoprim, 320 mg and sulfamethoxazole, 1600 mg)
Number of subjects: 255

Group type: COMPARATOR
Intervention: 10-day treatment (trimethoprim, 160 mg and sulfamethoxazole, 800 mg, twice daily)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Single-dose treatment
Number of subjects: 255

Group type: COMPARATOR
Intervention: 10-day treatment
Number of subjects: 255
Study: 31359499

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily plus a four-drug regimen (amoxicillin, clarithromycin, bismuth, and esomeprazole) for 14 weeks
Number of subjects: 220

Group type: COMPARATOR
Intervention: Four-drug regimen (amoxicillin, clarithromycin, bismuth, and esomeprazole) for 14 days
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Atorvastatin plus four-drug regimen
Number of subjects: 220
Study: 29205707

Group type: EXPERIMENTAL
Intervention: Short-term intensive voice training (IVT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Longer-term traditional voice training (TVT)
Number of subjects: 20
Study: 27613357

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg oral dose prior to RAPN
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 25298158

Group type: EXPERIMENTAL
Intervention: Regular psychotherapy plus a web-based depression program ('deprexis')
Number of subjects: 800

Group type: COMPARATOR
Intervention: Regular psychotherapy
Number of subjects: 800
Study: 22079914

Group type: EXPERIMENTAL
Intervention: Microdermabrasion treatment sessions (maximum 20 sessions over the course of a year)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control scar (nontreated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microdermabrasion treatment
Number of subjects: 0
Study: 20419572

Group type: EXPERIMENTAL
Intervention: Monetary incentive condition
Number of subjects: 610

Group type: COMPARATOR
Intervention: Nonincentive condition
Number of subjects: 610
Study: 17279844

Group type: EXPERIMENTAL
Intervention: Detection of angry expressions on male faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection of happy expressions on female faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutrally expressive faces
Number of subjects: 0
Study: 15644543

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sirolimus stent
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Paclitaxel stent
Number of subjects: 300
Study: 12111597

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once daily for 3 days)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Clarithromycin (500 mg twice daily for 7 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Clarithromycin and Azithromycin
Number of subjects: 18
Study: 10594490

Group type: EXPERIMENTAL
Intervention: Four times a day placebo regimen
Number of subjects: 3325

Group type: COMPARATOR
Intervention: Twice a day placebo regimen
Number of subjects: 3325
Study: 9122001

Group type: EXPERIMENTAL
Intervention: TRH test (0.4 mg i.v.)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: TRH and TRH with naloxone (2 mg i.v.)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Naloxone during TRH test
Number of subjects: 39
Study: 1678705

Group type: EXPERIMENTAL
Intervention: Celiprolol (0.15 mg kg‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 30
Study: 6410436

Group type: EXPERIMENTAL
Intervention: Community psychiatric nurses (CPN) as the main therapist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine out‐patient psychiatrist follow‐up
Number of subjects: 0
Study: 29855319

Group type: EXPERIMENTAL
Intervention: Alkalizing diet (BASE)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Acidizing diet (ACID)
Number of subjects: 11
Study: 26975417

Group type: EXPERIMENTAL
Intervention: Balance training (40 min per day, 2 times a week for 8 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no balance training)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 32
Study: 24748218

Group type: EXPERIMENTAL
Intervention: Chronic inflammation in benign prostate tissue
Number of subjects: 400
Study: 22741259

Group type: EXPERIMENTAL
Intervention: Pine needle moxibustion (group A)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Medicated thread moxibustion of Zhuang medicine (group B)
Number of subjects: 43
Study: 20224376

Group type: EXPERIMENTAL
Intervention: CHIVA method (n = 167)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Stripping with clinic marking (n = 167)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Stripping with duplex marking (n = 167)
Number of subjects: 501
Study: 17365543

Group type: EXPERIMENTAL
Intervention: Self-modelling intervention (viewing oneself perform an adaptive behaviour)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Self-observation intervention (viewing oneself perform at current skill level)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (physical practice only)
Number of subjects: 33
Study: 16373264

Group type: EXPERIMENTAL
Intervention: ACIST injection system (n=252)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Manual contrast injection (control; n=198)
Number of subjects: 450
Study: 11973193

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 120

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 120
Study: 11593638

Group type: EXPERIMENTAL
Intervention: Hepatitis B immune globulin (HBIG) injected during pregnancy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no HBIG injection)
Number of subjects: 48
Study: 7598419

Group type: EXPERIMENTAL
Intervention: Continuous extrapleural intercostal nerve block combined with opiate and non-steroidal anti-inflammatory drug premedication
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Continuous extrapleural intercostal nerve block
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Effective perioperative analgesia
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Zero pain score, complete preservation of preoperative lung function, prevention of the stress response to trauma
Number of subjects: 56
Study: 2089821

Group type: EXPERIMENTAL
Intervention: Flumazenil (n = 20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 30
Study: 419164

Group type: EXPERIMENTAL
Intervention: Single oral dosages of psychotropic drugs (neuroleptics, antidepressants, anxiolytics, psychostimulants)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 75
Study: 30112603

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no CBT)
Number of subjects: 98
Study: 27633728

Group type: EXPERIMENTAL
Intervention: Objectively-measured outdoor time
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Steps-per-day
Number of subjects: 192
Study: 26217929

Group type: EXPERIMENTAL
Intervention: Electronic goal reminders (text or email)
Number of subjects: 76

Group type: COMPARATOR
Intervention: No electronic goal reminders
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Electronic goal reminders at both visits
Number of subjects: 76
Study: 23507124

Group type: EXPERIMENTAL
Intervention: High lactate levels at the end of surgery (3.6 mmol/L)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: High lactate levels immediately after ICU admission (0 hour) (4.4 mmol/L)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: High lactate levels 6 hours after ICU admission (4.0 mmol/L)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: High lactate levels 12 hours after ICU admission (2.3 mmol/L)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction (LVEF) lower than 40%
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Higher EuroSCORE
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Red blood cell transfusion
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Lactate levels 6 hours after ICU admission
Number of subjects: 502
Study: 21195256

Group type: EXPERIMENTAL
Intervention: Quad-helix appliance
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Expansion plate
Number of subjects: 99

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 99
Study: 19188877

Group type: EXPERIMENTAL
Intervention: Moisture chamber (Q6H lubrication, eyelid closure and moisture chamber)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Standard therapy (Q6H lubrication and eye closure)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Both eyes (control and treatment)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Overall incidence
Number of subjects: 207
Study: 17409323

Group type: EXPERIMENTAL
Intervention: Multivitamins
Number of subjects: 8468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8468
Study: 15342805

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus radiation therapy
Number of subjects: 636

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 636
Study: 11773946

Group type: EXPERIMENTAL
Intervention: Biologic therapies (anti-tumour necrosis factor-alpha, interleukin-10, interleukin-11, anti-integrin antibody, antisense intercellular adhesion molecule-1 oligonucleotide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Older therapies (5-acetylsalicylic acid, corticosteroids, azathioprine)
Number of subjects: 0
Study: 9553680

Group type: EXPERIMENTAL
Intervention: 50 mg talinolol
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 100 mg talinolol
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 200 mg talinolol
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 100 mg talinolol (twice daily)
Number of subjects: 97
Study: 8713783

Group type: EXPERIMENTAL
Intervention: Nafamostat mesilate (NM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Heparin alone)
Number of subjects: 0
Study: 2282090

Group type: EXPERIMENTAL
Intervention: Lovastatin therapy
Number of subjects: 14
Study: 7211918

Group type: EXPERIMENTAL
Intervention: Intermittent intravenous heparin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous intravenous heparin therapy
Number of subjects: 0
Study: 30576246

Group type: EXPERIMENTAL
Intervention: Intravenous GH bolus
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intravenous saline bolus
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 72 h of fasting
Number of subjects: 18
Study: 27785646

Group type: EXPERIMENTAL
Intervention: Interactive DVD educational tool
Number of subjects: 2

Group type: COMPARATOR
Intervention: Arthritis Research UK leaflet
Number of subjects: 2
Study: 26526385

Group type: EXPERIMENTAL
Intervention: DMF BID (240 mg, twice daily)
Number of subjects: 2301

Group type: EXPERIMENTAL
Intervention: DMF TID (240 mg, three times daily)
Number of subjects: 2301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2301
Study: 24417529

Group type: EXPERIMENTAL
Intervention: Primed (walking 1600 m prior to task)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Not primed (no prior walking)
Number of subjects: 34
Study: 21681084

Group type: EXPERIMENTAL
Intervention: Wellness Workbook (WW) intervention
Number of subjects: 141

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 141
Study: 19487605

Group type: EXPERIMENTAL
Intervention: Follow-up phone call from primary care practice within 72 hours of the initial PED visit
Number of subjects: 4246

Group type: COMPARATOR
Intervention: Control group (no follow-up phone call)
Number of subjects: 4246

Group type: EXPERIMENTAL
Intervention: Follow-up phone call from primary care practice
Number of subjects: 4246
Study: 17304887

Group type: EXPERIMENTAL
Intervention: Ciclesonide, 200 microg once daily for 6 weeks
Number of subjects: 471

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 471
Study: 15460498

Group type: EXPERIMENTAL
Intervention: Three-day pretreatment with lansoprazole 30 mg twice daily
Number of subjects: 76

Group type: COMPARATOR
Intervention: No pretreatment
Number of subjects: 76
Study: 11603907

Group type: EXPERIMENTAL
Intervention: Recurrent ischaemia detected by multilead ECG monitoring
Number of subjects: 995

Group type: COMPARATOR
Intervention: Control group (patients without recurrent ischaemia)
Number of subjects: 995
Study: 10225769

Group type: EXPERIMENTAL
Intervention: LDL apheresis fortnightly plus simvastatin 40 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colestipol 20 g plus simvastatin 40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 1392023

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate 240mg twice daily for four weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 3902375

Group type: EXPERIMENTAL
Intervention: Oral flupirtine maleate (100 to 200 mg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Oral pentazocine (50 to 100 mg)
Number of subjects: 66
Study: 30585335

Group type: EXPERIMENTAL
Intervention: Octanoic acid
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30531821

Group type: EXPERIMENTAL
Intervention: Dried apricots (GI = 42 ± 5)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Raisins (GI = 55 ± 5)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sultanas (GI = 51 ± 4)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dried apricots (GI = 57 ± 5) with displacement effect
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All dried fruits (displacing half carbohydrate in white bread)
Number of subjects: 10
Study: 27435438

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone (0.1 mg/kg) 10 minutes before surgery over 2 minutes
Number of subjects: 46

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study: 24625502

Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intense Pulsed Light (IPL)
Number of subjects: 19
Study: 22951305

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1498

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 1498
Study: 20639026

Group type: EXPERIMENTAL
Intervention: 0.25 mg serlopitant
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: 1 mg serlopitant
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: 4 mg serlopitant
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: 4 mg tolterodine
Number of subjects: 557

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Serlopitant (all doses)
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Serlopitant
Number of subjects: 557
Study: 17661544

Group type: EXPERIMENTAL
Intervention: Interpretive group psychotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive group psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interpretive and supportive group psychotherapy
Number of subjects: 0
Study: 16246964

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg, n=19)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (n=16)
Number of subjects: 35
Study: 12072897

Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (LCT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) and long-chain triglycerides (LCT)
Number of subjects: 22
Study: 10084097

Group type: EXPERIMENTAL
Intervention: GHB
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRO
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 30
Study: 7727326

Group type: EXPERIMENTAL
Intervention: 0.375% bupivacaine plus 1 microgram/kg fentanyl (group A)
Number of subjects: 11

Group type: COMPARATOR
Intervention: 0.25% bupivacaine plus 1 microgram/kg fentanyl (group B)
Number of subjects: 11
Study: 1746730

Group type: EXPERIMENTAL
Intervention: Closed peritoneal lavage
Number of subjects: 220

Group type: COMPARATOR
Intervention: Open peritoneal lavage
Number of subjects: 220
Study: 6642921

Group type: EXPERIMENTAL
Intervention: Group I (ex-mental patient in the process of rehabilitation)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Group II (ex-mental patient who had successfully completed rehabilitation)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Group III (normal person)
Number of subjects: 72
Study: 31060760

Group type: EXPERIMENTAL
Intervention: 4 mg/kg racemic ketamine + 0.5 mg/kg midazolam (K-4 group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 6 mg/kg racemic ketamine + 0.5 mg/kg midazolam (K-6 group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 8 mg/kg racemic ketamine + 0.5 mg/kg midazolam (K-8 group)
Number of subjects: 90
Study: 29468633

Group type: EXPERIMENTAL
Intervention: Vaginal prostaglandin (PG)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 184
Study: 26154337

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Exercise (MIE)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise (HIE)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 18
Study: 24763694

Group type: EXPERIMENTAL
Intervention: Cationic antimicrobial peptide LL-37 at sub-inhibitory concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cationic antimicrobial peptide LL-37
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reactive oxygen species
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polymorphonucleocytes (PMNs)
Number of subjects: 0
Study: 22138444

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (30 minute workouts, 5 times/week for 16 weeks)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 212
Study: 19844249

Group type: EXPERIMENTAL
Intervention: Early initiation of estrogen therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late initiation of estrogen therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Estrogen therapy
Number of subjects: 0
Study: 17851781

Group type: EXPERIMENTAL
Intervention: D(2) dissection
Number of subjects: 1316

Group type: EXPERIMENTAL
Intervention: D(2) dissection with splenectomy (or pancreatico‐splenectomy)
Number of subjects: 1316

Group type: COMPARATOR
Intervention: D(1) dissection
Number of subjects: 1316
Study: 15933313

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate treatment in trial participants (Magpie Trial)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group (non-participants)
Number of subjects: 408
Study: 11753162

Group type: EXPERIMENTAL
Intervention: Pureed beef
Number of subjects: 18

Group type: COMPARATOR
Intervention: Iron-fortified infant rice cereal
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Addition of human milk to beef
Number of subjects: 18

Group type: COMPARATOR
Intervention: Addition of human milk to cereal
Number of subjects: 18
Study: 10366994

Group type: EXPERIMENTAL
Intervention: clopidogrel 75 mg once daily for 11 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: naproxen 250 mg b.i.d. for 7 days + placebo for 11 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: naproxen 250 mg b.i.d. for 7 days + clopidogrel 75 mg once daily for 11 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: naproxen + placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: naproxen + clopidogrel
Number of subjects: 30
Study: 8032704

Group type: EXPERIMENTAL
Intervention: Granisetron 40 micrograms/kg
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Granisetron 160 micrograms/kg
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Granisetron (both doses)
Number of subjects: 355
Study: 3187474

Group type: COMPARATOR
Intervention: Vitalograph Compact (C)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vitalograph Alpha (A)
Number of subjects: 20
Study: 29847222

Group type: EXPERIMENTAL
Intervention: Telemedicine-Based Health Coaching (VC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: In-person Health Coaching (IP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study: 28221048

Group type: EXPERIMENTAL
Intervention: Positively framed message about PBS use
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Negatively framed message about PBS use
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 62
Study: 25673206

Group type: EXPERIMENTAL
Intervention: Cook double balloon dilation (Cook group)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Intra-amniotic injection of ethacridine lactate (EL group)
Number of subjects: 55
Study: 22510992

Group type: EXPERIMENTAL
Intervention: Single cleansing
Number of subjects: 1923

Group type: EXPERIMENTAL
Intervention: Multiple cleansing
Number of subjects: 1923

Group type: COMPARATOR
Intervention: No chlorhexidine
Number of subjects: 1923
Study: 20074228

Group type: EXPERIMENTAL
Intervention: Combination of acetylsalicyclic acid (ASA), acetaminophen, and caffeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy with single substances (ASA, acetaminophen, or caffeine)
Number of subjects: 0
Study: 17450358

Group type: EXPERIMENTAL
Intervention: Written information sheet explaining the risks of surgery (group 2)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Routine consent with verbal explanations (group 1)
Number of subjects: 53
Study: 16205558

Group type: EXPERIMENTAL
Intervention: Pegaptanib sodium (0.3 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care (sham injections)
Number of subjects: 64
Study: 11839850

Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10424554

Group type: EXPERIMENTAL
Intervention: Immediate arthroscopic stabilization (group S)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Immobilization for 3 weeks followed by rehabilitation (group T)
Number of subjects: 40
Study: 7749987

Group type: COMPARATOR
Intervention: Group R (cold storage workers)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Group C (general storehouse workers)
Number of subjects: 18
Study: 1691382

Group type: EXPERIMENTAL
Intervention: Propranolol (2 x 80 mg/day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pindolol (2 x 10 mg/day)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7